1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[[4-[6-[1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]triazol-4-yl]-2-pyridyl]triazol-1-yl]methyl]tetrahydrofuran-2-yl]pyrimidine-2,4-dione

ID: ALA3596228

Chembl Id: CHEMBL3596228

PubChem CID: 73213415

Max Phase: Preclinical

Molecular Formula: C24H27N9O10

Molecular Weight: 601.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](Cn3cc(-c4cccc(-c5cn([C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)n4)nn3)[C@@H](O)[C@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C24H27N9O10/c34-9-15-18(37)19(38)21(40)23(43-15)33-7-13(28-30-33)11-3-1-2-10(25-11)12-6-31(29-27-12)8-14-17(36)20(39)22(42-14)32-5-4-16(35)26-24(32)41/h1-7,14-15,17-23,34,36-40H,8-9H2,(H,26,35,41)/t14-,15-,17-,18-,19+,20-,21-,22-,23-/m1/s1

Standard InChI Key:  XDEZXCACUJLRGB-XMDWOKKKSA-N

Associated Targets(Human)

OGT Tchem UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 601.53Molecular Weight (Monoisotopic): 601.1881AlogP: -4.26#Rotatable Bonds: 7
Polar Surface Area: 269.01Molecular Species: NEUTRALHBA: 18HBD: 7
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: -2.62CX LogD: -2.63
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.11Np Likeness Score: 0.04

References

1. Wang S, Shen DL, Lafont D, Vercoutter-Edouart A, Mortuaire M, Shi Y, Maniti O, Girard-Egrot A, Lefebvre T, Pinto BM, Vocadlo D, Vidal S.  (2014)  Design of glycosyltransferase inhibitors targeting human O-GlcNAc transferase (OGT),  (8): [10.1039/C4MD00063C]

Source